Holen Sie sich die Stockscreener-App
13.29
0.61%
0.08
Mediwound Ltd Aktie (MDWD) Neueste Nachrichten
Director of MediWound (NASDAQ: MDWD) trades shares via spouse - Stock Titan
An FDA-approved burn treatment company’s CEO will join a New York fireside chat. - Stock Titan
Precision Trading with Mediwound Ltd. (MDWD) Risk Zones - Stock Traders Daily
MediWound (NASDAQ: MDWD) seller Hess plans $50K, 3,958-share sale - Stock Titan
MediWound (MDWD) Q2 2026 Earnings Call Transcript - AOL.ca
MediWound (MDWD) Q2 2026 Results: The Available Earnings Metric Delivers a Beat in the Current Update; Closing Reaction: The Stock Records a 1.87% Increase in the Current UpdateRevenue Per Share - vinanet.vn
MediWound (MDWD) Q2 2026 Results: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Share-Price Check: Shares Move 1.87% Up on the DayNegative Surprise Momentum - dars.gov.et
What is HC Wainwright's Forecast for MediWound Q3 Earnings? - MarketBeat
Weekly Recap: Reaffirmed 2026 guidance and EscharEx Phase III enrollment - TradingView
MDWD Looks 30.8% Overvalued on GF Value™ - GuruFocus
Mediwound Ltd (MDWD) Stock News Today - TradingKey
MediWound Ltd. (NASDAQ:MDWD) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates - simplywall.st
MediWound Ltd. (NASDAQ:MDWD) Just Released Its Second-Quarter Earnings: Here's What Analysts Think - Moomoo
Maxim Group Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $30 - Moomoo
MediWound (MDWD) Stock Faces Cash Burn As Revenue Slips - simplywall.st
Wall Street Zen Downgrades MediWound (NASDAQ:MDWD) to Strong Sell - MarketBeat
MediWound Q2 2026 Earnings Call: Complete Transcript - Sahm
A Quick Look at Today's Ratings for MediWound(MDWD.US), With a Forecast Between $22 to $36 - Moomoo
MDWD Maintains by Oppenheimer -- Price Target Lowered to $30.00 - GuruFocus
T. Rowe Price Associates (MDWD) discloses 5.0% ownership in Mediwound common stock - Stock Titan
MediWound Ltd. Q2 2026 Earnings Call Summary - Yahoo Finance
H.C. Wainwright Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $36 - Moomoo
MediWound (MDWD) Earnings Call zu Q2 2026: VALU auf Kurs, Prognose bekräftigt - TradingKey
Key facts: MediWound Ltd. (MDWD) Q2 $3.09M rev; EscharEx $4B target - TradingView
Q2 2026 Mediwound Ltd Earnings Call Transcript - GuruFocus
Mediwound earnings missed by $0.03, revenue topped estimates - Investing.com Canada
MediWound (NASDAQ:MDWD) Issues Earnings Results - MarketBeat
MediWound Ltd (MDWD) (Q2 2026) Earnings Call Highlights: Record - GuruFocus
MediWound Ltd (MDWD) (Q2 2026) Earnings Call Highlights: Record NexoBrid Sales and EscharEx ... - ca.finance.yahoo.com
A. G. P. Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $22 - Moomoo
MediWound Q2 2026 Earnings Call Transcript - MarketBeat
MediWound Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: MediWound tops Q2 2026 revenue forecast as shares rise - Investing.com
Mediwound Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
Mediwound Ltd. Reaffirms Revenue Guidance for the Full-Year 2026 - marketscreener.com
MediWound Q2 sales beat estimates; EPS miss widens as R&D rises - scanx.trade
MediWound Ltd. (MDWD) Q2 FY2026 earnings call transcript - Yahoo Finance
MediWound (MDWD) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
MDWD: Q2 revenue fell, but guidance held as EscharEx and NexoBrid programs advanced and U.S. sales grew - TradingView
MediWound Q2 2026 Results Highlight EscharEx Trial Progress and New NexoBrid BARDA Agreement - TipRanks
MEDIWOUND ($MDWD) Releases Q2 2026 Earnings - Quiver Quantitative
MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
MediWound: Q2 Earnings Snapshot - Barchart.com
MDWD: Validated enzymatic therapies drive strong growth, targeting $1B+ peak sales in chronic wounds - TradingView
MediWound (NASDAQ: MDWD) revenue drops in H1 2026 but guidance held - Stock Titan
MediWound's Phase III Wound Trial Targets 216 Patients at About 40 Sites - Stock Titan
Technical Reactions to MDWD Trends in Macro Strategies - Stock Traders Daily
Mediwound Ltd expected to post a loss of 76 cents a shareEarnings Preview - TradingView
Mediwound Ltd (MDWD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MediWound (MDWD) Holds Gains: Modest Advance Points to Consolidation Near $14.39BPI Reversal - dars.gov.et
MediWound (NASDAQ:MDWD) Stock Price Crosses Below 200-Day Moving AverageHere's What Happened - MarketBeat
MediWound (MDWD) Expected to Release Earnings on Thursday - MarketBeat
MediWound Ltd. Revenue Breakdown – FWB:M8W - TradingView
MDWD Q1 2026 Earnings: Narrower Loss of -$0.23 Per Share Beats Estimates by 65.57%Earnings Quality Analysis - Vinanet
Trading the Move, Not the Narrative: (MDWD) Edition - Stock Traders Daily
MDWD Q1 2026 Earnings: Significant EPS Beat Amidst Missing Revenue DataROA Comparison - Vinanet
MediWound to Report Second Quarter 2026 Financial Results - GlobeNewswire
MDWD|Mediwound Ltd|Price:14.500|Chg%:+0.270 - TradingKey
MediWound Ltd. Revenue Breakdown – BOATS:MDWD - TradingView
Mediwound Ltd (MDWD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
MDWD Q1 2026 Earnings: Significant Earnings Beat Despite Revenue AbsenceSpecial Dividend Alert - dars.gov.et
0.86%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):